Aravax Future of Allergy Immunotherapy
Aravax Future of Allergy Immunotherapy: Next generation food allergy treatment – it’s not just a question of efficacy Pascal Hickey PhD, CEO, Aravax 12 May 2026 Read article
Eight allergy companies to watch in 2026
Eight allergy companies to watch in 2026 Labiotech April 15 2026 Read story [behind a paywall]
Food Allergy Treatment Market Is Set to Triple — What it Means for Patients
Food Allergy Treatment Market Is Set to Triple — What it Means for Patients SnackSafely.com 9 April 2026 Read story
Aravax Strengthens Board with Allergy Industry Experts
Aravax Strengthens Board with Allergy Industry Experts Startup Researcher 9 April 2026 Read story
Aravax adds allergy specialists to board as peanut therapy advances
Aravax adds allergy specialists to board as peanut therapy advances Discover Pharma 8 April 2026 Read story
Scrip Asks… What Does 2026 Hold For Biopharma?
Scrip Asks… What Does 2026 Hold For Biopharma? Scrip 6 February 2026 Read article
Science: The World’s Shared Language That Carried One Founder Across Continents
Science: The World’s Shared Language That Carried One Founder Across Continents Brandon Biocatalyst 30 November 2025 Read story
Aravax has appointed Louise Peacock as Chief Regulatory and Quality Officer
Aravax has appointed Louise Peacock as Chief Regulatory and Quality Officer PharmaTimes 18 June 2025 View news
Australia based Aravax is building out late stage manufacturing capabilities in Oxford, UK
Australia based Aravax is building out late stage manufacturing capabilities in Oxford, UK BiotechTV 21 February 2025 Watch here
Biotech Aravax establishes UK subsidiary at Oxford Science Park
Biotech Aravax establishes UK subsidiary at Oxford Science Park Insidermedia 15 November 2024 View news
